Logo - springer
Slogan - springer

Medicine | Chinese Medicine

Chinese Medicine

Chinese Medicine

Editor-in-Chief: Yi-tao Wang
Deputy Editor: Chunming Wang

ISSN: 1749-8546 (electronic version)

Journal no. 13020

BioMed Central

Open access BioMed Central
  • Official Journal of the International Society for Chinese Medicine, and offers merit- and need-based APC waivers
  • Quality content: evidence-based, scientifically justified and ethical research
  • Fast and thorough peer review: 12 days from submission to first decision

Chinese Medicine has a robust approach and strong focus on publishing evidence-based, scientifically justified research and review papers, across a significant range of areas relevant to Chinese medicine. It is the official journal of the International Society for Chinese Medicine, based in Macau and sponsored by Fundação Macau. The journal is well established, having been indexed by SCIE since 2013, and welcomes submission of papers from across the globe every year, which help contribute to the advancement of knowledge in the field of Chinese medicine.

Related subjects » Medicine

Impact Factor: 1.508 (2016) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), PubMedCentral, SCOPUS, Google Scholar, CAB International, Academic OneFile, CAB Abstracts, CNKI, Current Abstracts, EBSCO Academic Search, EBSCO Biomedical Reference Collection, EBSCO CINAHL, EBSCO STM Source, EBSCO TOC Premier, Global Health, OCLC, SCImago, Summon by ProQuest

Read This journal on BioMed Central

For authors and editors


  • Journal Citation Reports®
    2016 Impact Factor
  • 1.508
  • Aims and Scope

    Aims and Scope

    Close

    Chinese Medicine is an open access journal publishing evidence-based, scientifically justified research and review papers in all aspects of Chinese medicine, including - but not limited to - chemistry, biology, pharmacology, pharmaceutics, engineering, clinical applications and socioeconomics that are relevant and significant to Chinese medicine.

    We particularly welcome studies using interdisciplinary methods and technologies to:
    - discover new compounds from Chinese medicinal herbs
    - elucidate molecular/cellular targets and mechanisms of action for Chinese medicine
    - develop modern drug delivery and molecular pharmaceutic tools for Chinese medicine
    - evaluate the outcomes of hypothesis-driven, rationally-designed fundamental, pre-clinical and clinical research

    We now publish research and review papers, both unsolicited and solicited. We may publish opinion or commentary papers which are by invitation only.

    Normally, we do not publish such types of papers as case study, technical note or meta-analysis unless the topic is of exceptionally significance and urgency.

  • Submit Online
  • English Language Editing

    English Language Editing

    Close

  • Writing Resources: Training for Authors